(June 11, 2018, 2:22 PM EDT) -- PHILADELPHIA — The Pennsylvania Superior Court on June 8 affirmed that a father’s claim that his son’s overdose death was caused by the off-label promotion of the opioid Actiq are preempted by federal law (Joseph A. Caltagirone, et al. v. Cephalon, Inc., et al., No. 1301 EDA 2017, Pa. Super., 2018 Pa. Super. LEXIS 628)....